Corporate Breaking News
Corporate Breaking News
Home : ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx™ Endobronchial Coil System
Jun 11
2018

ELEVATE Study Aims to Improve Selection Criteria and Outcomes for Patients with Severe Emphysema Treated with the PneumRx™ Endobronchial Coil System

LONDON, June 11, 2018 /PRNewswire/ -- Recruitment Begins in 7 European Countries BTG plc (LSE: BTG), the global healthcare company, today announces the start of ELEVATE: A randomizEd ControlLed Study of PnEumRx™ Endobronchial Coil System (Coils) Versus Standard of Care Medical...
Source:https://www.prnewswire.com/news-releases/elevate-study-aims-to-improve-selection-criteria-and-outcomes-for-patients-with-severe-emphysema-treated-with-the-pneumrx-endobronchial-coil-system-685096331.html
 
Related News
» The9 Limited Regains Compliance with Nasdaq Listing Requirements
» Infogram expandiert nach Akquisition durch Prezi in der DACH-Region
Home
About us
Archive
Sitemap
Powered By Corporate Breaking News.com Home| About us| Archive News| Sitemap